Rapid Molecular Test for Flu and COVID-19 on FINDER Platform Gets FDA Clearance and CLIA-Waiver
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read MorePosted by CLP Edit Staff | Mar 31, 2026 | Flu & Respiratory Infections |
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read MorePosted by CLP Edit Staff | Mar 31, 2026 | Urinalysis & Toxicology |
A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.
Read MorePosted by CLP Edit Staff | Mar 30, 2026 | Information Technology |
The integration gives more than 4,700 oncology providers across 1,600-plus community cancer care centers direct access to order and receive results from multiple precision oncology tests within a single clinical workflow.
Read MorePosted by CLP Edit Staff | Mar 30, 2026 | Dementias & Alzheimer’s |
BRAINBox Solutions reports near-completion of its HeadSMART II trial for a concussion blood test, supporting an upcoming FDA submission, and advances in a point-of-care biomarker collaboration with Prolight Diagnostics.
Read MorePosted by CLP Edit Staff | Mar 30, 2026 | Clinical Chemistry Analyzers |
The FDA has cleared Roche’s cobas c 703 and cobas ISE neo, high-throughput analytical units designed to automate workflows and address staffing and capacity challenges.
Read More